Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Safety and Immunologic Activity of Multiple Infusions of APN401

Next Previous
X
Search
Trial Profile

Safety and Immunologic Activity of Multiple Infusions of APN401

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 21 Apr 2023

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs APN 401 (Primary)
  • Indications Appendiceal cancer; Brain metastases; Colorectal cancer; Head and neck cancer; Pancreatic cancer; Solid tumours; Squamous cell cancer
  • Focus Adverse reactions

    • Most Recent Events

    • 18 Apr 2023 Results presented in an invIOs media release.
    • 18 Apr 2023 According to an invIOs media release, company today announced data from a poster showing two patient case studies from this clinical trial of APN401 during the American Association for Cancer Research (AACR) Annual Meeting in Orlando, Florida.
    • 24 Nov 2021 Status changed from active, no longer recruiting to completed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top